Avanafil may modestly lower blood pressure, so concomitant use with antihypertensives should be monitored. If blood pressure falls below the patient's baseline, dosage adjustment of either medication may be required under medical supervision.
A prolonged erection (priapism) is a medical emergency. Seek immediate care at the nearest emergency department; prompt treatment reduces the risk of permanent damage.
Manufacturers may use different imprint codes or colour schemes for the same dosage. The imprint typically includes the brand name “Top Avana” and the strength “30 / 50 mg”. Verify the imprint with your pharmacist if you receive a different visual.
Yes, but you should carry the medication in its original labelled container, accompanied by a copy of the prescription and a brief letter from your prescriber. Some countries have strict import rules for combination products, so check the destination’s regulations beforehand.
Standard occupational drug screens do not test for avanafil or dapoxetine. However, if the employer uses specialized panels, disclose your prescription to the occupational health service to avoid misunderstandings.
Pharmacologically the combination provides the same active ingredients as taking the two medicines individually. The fixed-dose tablet may improve convenience, but it also fixes the dose ratio, limiting flexibility for dose titration.
Avanafil was first described in the early 2000s as a rapid-onset PDE5 inhibitor, offering faster absorption than earlier agents such as sildenafil. It received FDA approval in 2012 and subsequently gained approval in several EU countries, including the UK.
Pricing varies by pharmacy and whether a generic version is available. While a single tablet may reduce the number of prescriptions, patients should discuss cost considerations with their prescriber or pharmacist.
Bathrooms often have high humidity and temperature fluctuations, which can degrade the tablet. It is best to store the medication in a cool, dry place such as a bedroom drawer or a cabinet away from moisture.
Dapoxetine can influence mood. In men with a history of depression, clinicians usually monitor mood symptoms closely after initiating therapy and may adjust treatment if depressive signs emerge.
Top Avana is a combined oral pill that contains two active pharmaceutical ingredients: avanafil and dapoxetine. Avanafil belongs to the phosphodiesterase-type 5 (PDE5) inhibitor class and is used to treat erectile dysfunction (ED). Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of premature ejaculation (PE).
In the United Kingdom the two components are each authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) as separate prescription medicines. A fixed-dose combination marketed under the name Top Avana is not listed on the MHRA’s authorised product register, so the product is considered an off-label formulation that must be prescribed with caution. The tablet is supplied in a strength of 30 mg avanafil / 50 mg dapoxetine and is intended for adult men who experience both ED and PE.
Avanafil selectively inhibits the PDE5 enzyme that normally degrades cyclic guanosine monophosphate (cGMP) in the corpus cavernosum. By blocking PDE5, avanafil allows cGMP to accumulate after sexual stimulation, leading to smooth-muscle relaxation, increased blood flow, and erection. The drug has a rapid onset of action (as early as 15 minutes) and a relatively short plasma half-life, which contributes to its favourable timing profile for on-demand use.
Dapoxetine exerts its effect by transiently increasing the synaptic concentration of serotonin through inhibition of the serotonin reuptake transporter (SERT). Elevated serotonin levels modulate the ejaculatory reflex arc within the central nervous system, lengthening the intravaginal ejaculatory latency time (IELT). Because dapoxetine is rapidly absorbed and cleared (half-life ≈ 1.5 hours), it is taken shortly before sexual activity to minimise systemic exposure and related side effects.
When both agents are taken together, avanafil addresses the vascular component of erectile function while dapoxetine acts on the neuro-behavioral control of ejaculation, potentially offering complementary benefit for men with co-existing ED and PE.
Because Top Avana contains both agents, it may be prescribed off-label for men who experience both conditions simultaneously. The decision to use the combination should be based on a clinical assessment that confirms the need for treatment of both ED and PE and that excludes contraindications for either component.
The fixed-dose combination of avanafil and dapoxetine has not undergone dedicated large-scale clinical trials. However, small open-label studies and expert consensus suggest that treating both the vascular and ejaculatory pathways may improve overall sexual satisfaction in men with dual pathology.
Off-label use requires medical supervision and an individualized risk-benefit assessment. The prescriber should document the rationale for combining these agents and monitor the patient closely for adverse events.
If any of the above conditions are present, the prescriber should consider alternative therapies or adjust the treatment plan accordingly.
These reactions typically diminish as the body adapts to the medication.
Patients should provide a full medication list, including over-the-counter products and supplements, before starting Top Avana.
Regular follow-up visits enable dose optimisation and early detection of adverse events.
This article provides educational information about Top Avana and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
